AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2018
Sep 14, 2018
31676_dirs_2018-09-14_2a0a4277-3ec1-43e7-b4a3-39a1b8fd8de0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-09-11
Reporting Person: Schrepfer Robert W (SVP - New Bus Dev & Spec Sales)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-09-11 | Common Stock | M | 28688 | $6.60 | Acquired | 47842 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-09-11 | Option to Purchase | $6.60 | M | 28688 | Disposed | 2023-07-31 | Common Stock (26688) | Direct |
Footnotes
F1: Option vests over a four year period beginning on the first anniversary of August 1, 2013.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3